Teva to Report Fourth Quarter 2014 Financial Results on February 5, 2015
Jerusalem, January 15, 2015 - Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) announced today that
it will release its fourth quarter 2014 financial results on Thursday,
February 5, 2015 at 7:00 a.m. ET.
Teva will host a conference call and live webcast on the same day, at 8:00 a.m. ET to discuss its
fourth quarter 2014 results and overall business environment. A Question & Answer session will
follow this discussion.
In order to participate, please dial the following numbers (at least 10 minutes before the
scheduled start time): United States 1-866-434-1115; Canada 1-866-992-3607 International +44(0)
1452 589509; passcode: 66308620. For a list of other international toll-free numbers, click
here.
A live webcast of the call will also be available on Tevas website at: www.tevapharm.com. Please
log in at least 10 minutes prior to the conference call in order to download the applicable audio
software.
Following the conclusion of the call, a replay of the webcast will be available within 24 hours on
the Companys website. The replay can also be accessed until March 12, 2015, 10:00 a.m. ET by
calling United States 1-866-247-4222; Canada 1-866-878-9237 or International +44(0) 1452 550000;
passcode: 66308620.
About Teva
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) is a leading global pharmaceutical company,
committed to increasing access to high-quality healthcare by developing, producing and marketing
affordable generic drugs as well as innovative and specialty pharmaceuticals and active
pharmaceutical ingredients. Headquartered in Israel, Teva is the worlds leading generic drug
maker, with a global product portfolio of more than 1,000 molecules and a direct presence in
approximately 60 countries. Tevas Specialty Medicines businesses focus on CNS, respiratory,
oncology, pain, and womens health therapeutic areas as well as biologics. Teva currently employs
approximately 45,000 people around the world and reached $20.3 billion in net revenues in 2013.
Teva Pharmaceutical Indu... (NYSE:TEVA)
Graphique Historique de l'Action
De Juin 2024 à Juil 2024
Teva Pharmaceutical Indu... (NYSE:TEVA)
Graphique Historique de l'Action
De Juil 2023 à Juil 2024